Instructions for use and medication precautions for Trelagliptin

Trelagliptin (Trelagliptin) is a DPP-4 inhibitor widely used to treat type 2 diabetes. It helps control postprandial blood sugar fluctuations by inhibiting the activity of DPP-4 enzyme, enhancing insulin secretion and reducing blood sugar levels. As a long-term blood sugar control drug, trotagliptin needs to strictly follow the instructions for use, and patients should also pay attention to some key matters during use.

Patients must strictly follow dietary and exercise regimen recommendations while taking trotagliptin. The treatment of diabetes does not rely solely on medications. A healthy diet and regular exercise are crucial to controlling blood sugar. Patients should adjust their eating habits under the guidance of a doctor, reduce the intake of high-sugar and high-fat foods, and combine them with appropriate exercise to improve insulin sensitivity and promote blood sugar consumption.

Trelagliptin may cause hypoglycemia, especially when used in combination with other antidiabetic agents. Therefore, patients need to monitor blood sugar levels closely, especially while taking this drug. If symptoms of hypoglycemia occur, such as dizziness, fatigue, palpitations, etc., you should immediately take sugary foods such as sugar, glucose or soft drinks to relieve the symptoms. If patients are also taking drugs that delay sugar absorption (such as voglibose or acarbose), they need to pay special attention to the occurrence of hypoglycemia symptoms and take glucose in a timely manner to correct blood sugar levels.

While taking trotagliptin, patients should also avoid operating dangerous machinery, such as working at heights or driving a car, especially if symptoms of hypoglycemia occur. This is because low blood sugar can cause slow reactions or confusion, increasing the risk of an accident. Patients should inform their family members or those around them that they are taking this medicine so that they can receive timely help if symptoms of hypoglycemia occur.

Reference materials:https://en.wikipedia.org/wiki/Trelagliptin